In a meeting with nearly two dozen leaders representing consumers, insurers, providers and business leaders, Health and Human Services Secretary Sylvia Burwell on Jan. 26 announced measurable goals and a timeline to move the Medicare program, and the healthcare system at large, toward paying providers based on the quality of care they give patients.
The National Association of Chain Drug Stores has submitted a statement to the U.S. House Committee on Energy and Commerce Subcommittee on Health expressing concerns about pharmacy-related budget proposals.
If its goal of expanding health coverage to more Americans is fully realized, the Affordable Care Act could end up pulling as many as 30 million more people into the ranks of the newly insured. That means rising prescription counts and more patients at pharmacy counters and in drug store aisles, but it also poses challenges in managing and educating patients about their benefits.
On the heels of Wednesday’s news that the U.S. House of Representatives introduced bipartisan legislation that would formally designate pharmacists as healthcare providers under Medicare Part B, the U.S. Senate has followed suit with a companion bill.
Several of the nation’s largest healthcare systems and payers on Tuesday announced a powerful new private-sector alliance dedicated to accelerating the transformation of the U.S. healthcare system to value-based business and clinical models.
Partner up or risk being left behind. That’s the choice facing more and more pharmacy groups grappling with accountable care, outcomes-based reimbursement and risk-sharing collaborative health networks.
A new analysis by researchers at Brigham and Women's Hospital and the CVS Health Research Institute, published online first in the American Journal of Public Health, shows that enhanced prescription drug insurance can improve patient health outcomes and reduce use of other (often costly) healthcare services.
CMS issued a proposed 428-page rule change earlier this week that would offer health systems more flexibility regarding the agency's accountable care program, PwC's Health Research Institute noted Friday.